Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSORIASIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT02775500
What this trial is testing

Apremilast Pregnancy Exposure Registry

Who this might be right for
Psoriatic ArthritisPsoriasis
University of California, San Diego 233
Large-scale testing (Phase 3)Study completedNCT01194219
What this trial is testing

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 844
Not applicableNot Yet RecruitingNCT07648836
What this trial is testing

Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Who this might be right for
Ankylosing SpondylitisPsoriasis
Assiut University 90
Not applicableStudy completedNCT04428411
What this trial is testing

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Who this might be right for
Plaque Psoriasis
Pfizer 486
Not applicableStudy completedNCT02191007
What this trial is testing

Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis

Who this might be right for
Psoriasis
Xijing Hospital 230
Testing effectiveness (Phase 2)Study completedNCT02483234
What this trial is testing

Psoriasis-Arthritis & Bone Program

Who this might be right for
PsoriasisPsoriatic Arthritis
University of Erlangen-Nürnberg Medical School 40
Testing effectiveness (Phase 2)Study completedNCT01022502
What this trial is testing

Comparison of Refined and Crude Indigo Naturalis Ointment in Treating Psoriasis

Who this might be right for
Psoriasis Vulgaris
Yin-ku Lin 38
Post-approval studies (Phase 4)Study completedNCT00168753
What this trial is testing

Community Based Trial for AMEVIVE®

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Astellas Pharma Inc 114
Post-approval studies (Phase 4)Study completedNCT03440736
What this trial is testing

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Novartis Pharmaceuticals 781
Large-scale testing (Phase 3)Study completedNCT02065713
What this trial is testing

Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

Who this might be right for
Psoriatic Arthritis
Instituto de Medicina Molecular João Lobo Antunes 44
Not applicableStudy completedNCT03835780
What this trial is testing

The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study

Who this might be right for
Venous ThrombosesVenous ThromboembolismDeep Vein Thrombosis+6 more
Momentum Data 266,890
Large-scale testing (Phase 3)Active Not RecruitingNCT04908189
What this trial is testing

Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Who this might be right for
Psoriatic Arthritis
Bristol-Myers Squibb 729
Not applicableStudy completedNCT00407979
What this trial is testing

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

Who this might be right for
Atopic DermatitisPsoriasis
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableEnded earlyNCT04995783
What this trial is testing

Predicting Medication Response for Autoimmune Disease

Who this might be right for
Ulcerative ColitisCrohn's DiseasePsoriasis+1 more
Coral Genomics, Inc. 200
Post-approval studies (Phase 4)UnknownNCT01223976
What this trial is testing

Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis

Who this might be right for
TuberculosisPsoriasis
Tel-Aviv Sourasky Medical Center 150
Large-scale testing (Phase 3)Study completedNCT05120297
What this trial is testing

Efficacy and Safety of AK101 in Subjects With Psoriasis

Who this might be right for
Psoriasis Vulgaris
Akeso 452
Testing effectiveness (Phase 2)Study completedNCT01208090
What this trial is testing

ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Actelion 326
Large-scale testing (Phase 3)Study completedNCT02474082
What this trial is testing

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 202
Early research (Phase 1)Study completedNCT01043224
What this trial is testing

A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 24
Early research (Phase 1)Study completedNCT02097173
What this trial is testing

Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Who this might be right for
Psoriasis
medac GmbH 35
Next Page